SRCIN1 and breast cancer: The likelihood that expression and genomic profiling of SRCIN1/p140Cap might impact on the disease was first evaluated in human breast cancer (BC), one of the most common cancers with more than 2 million new cases in 2018 and 450,000 deaths each year worldwide [43, 44].